Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP856217.RAWgQdG6ZaOrgXjf7FZPLgNaPDFWioCxDFv9W7V6tNg5U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP856217.RAWgQdG6ZaOrgXjf7FZPLgNaPDFWioCxDFv9W7V6tNg5U130_assertion type Assertion NP856217.RAWgQdG6ZaOrgXjf7FZPLgNaPDFWioCxDFv9W7V6tNg5U130_head.
- NP856217.RAWgQdG6ZaOrgXjf7FZPLgNaPDFWioCxDFv9W7V6tNg5U130_assertion description "[This is the first study to show u-PAR as a target and marker of sensitivity to Cetuximab, and to delineate novel mechanisms leading to metastasis suppression of NSCLC by Cetuximab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856217.RAWgQdG6ZaOrgXjf7FZPLgNaPDFWioCxDFv9W7V6tNg5U130_provenance.
- NP856217.RAWgQdG6ZaOrgXjf7FZPLgNaPDFWioCxDFv9W7V6tNg5U130_assertion evidence source_evidence_literature NP856217.RAWgQdG6ZaOrgXjf7FZPLgNaPDFWioCxDFv9W7V6tNg5U130_provenance.
- NP856217.RAWgQdG6ZaOrgXjf7FZPLgNaPDFWioCxDFv9W7V6tNg5U130_assertion SIO_000772 19276367 NP856217.RAWgQdG6ZaOrgXjf7FZPLgNaPDFWioCxDFv9W7V6tNg5U130_provenance.
- NP856217.RAWgQdG6ZaOrgXjf7FZPLgNaPDFWioCxDFv9W7V6tNg5U130_assertion wasDerivedFrom befree-20140225 NP856217.RAWgQdG6ZaOrgXjf7FZPLgNaPDFWioCxDFv9W7V6tNg5U130_provenance.
- NP856217.RAWgQdG6ZaOrgXjf7FZPLgNaPDFWioCxDFv9W7V6tNg5U130_assertion wasGeneratedBy ECO_0000203 NP856217.RAWgQdG6ZaOrgXjf7FZPLgNaPDFWioCxDFv9W7V6tNg5U130_provenance.